Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity

Overview of attention for article published in Radiation Oncology, October 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 8,911 followers.

RT @Accuray: Encouraging outcomes and low toxicity for 42 inoperable non-metastatic #PancreaticCancer patients treated with #CyberKnife rep…

RT @Accuray: Encouraging outcomes and low toxicity for 42 inoperable non-metastatic #PancreaticCancer patients treated with #CyberKnife rep…

RT @Accuray: Encouraging outcomes and low toxicity for 42 inoperable non-metastatic #PancreaticCancer patients treated with #CyberKnife rep…

RT @Accuray: Encouraging outcomes and low toxicity for 42 inoperable non-metastatic #PancreaticCancer patients treated with #CyberKnife rep…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.